🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 528872302 (prev. 528872104 )
- Market Cap
- Mid Cap
- IPO
- 4/7/2000 · $22.00/share
Business: Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing breakthrough treatments for human disease. Lexicon has clinical-stage drug programs for diabetes, carcinoid syndrome, and other indications, all of which were discovered by Lexicon's research team. Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.
Notes: May 20, 2015 -- Lexicon Pharmaceuticals, Inc. (LXRX) will effect a one for seven (1-7) reverse stock split of its outstanding common stock. The reverse split will be effective at the opening of business on Thursday, May 21, 2015. In conjunction with the reverse split, the CUSIP number will change to 528872302.
Company Contact
- CEO
- Scott Coiante
- CFO
- Mike Exton
- Headquarters
- 2445 Technology Forest Blvd., 11th Floor, The Woodlands, TX 77381
- Phone
- 281-863-3000
- Fax
- 281-863-8088
- Investor Relations
- Chas Schultz · 281-863-3421 · cschultz@lexpharma.com